A recent lawsuit between pharmacy benefit manager Express Scripts and drugmaker Kaleo Inc. suggests that fixing the drug-pricing system will take more than just eliminating drug rebates.
Express Scripts claimed in the lawsuit that Kaleo had shorted it on $14.5 million in rebate payments related to Evzio, the drugmaker’s life-saving auto-injector that delivers the opioid overdose cure naloxone. Kaleo responded that it had made all payments that were due due, and had in fact been overcharged by Express Scripts by about $5 million.
The case was due for a jury trial in March 2019, but instead moved for alternative dispute ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.